Medherant targets drug delivery with Bostik

4 June 2015 - Deborah Wilkes

Archived

A new company called Medherant has signed a licensing deal with adhesive specialist Bostik that will help it develop "next generation" transdermal drug delivery systems for OTC medicines. Medherant is initially focusing on products for pain relief but aims to develop novel patch-based medicines for a range of conditions.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: